CXCR4 Modulator for Preventing Cancer Metastasis
Application
Amine derivatives as chemokine receptor type 4 (CXCR4) modulators to treat breast cancer and block tumor metastasis.
Key Benefits
New class of anti-cancer drugs targeting CXCR4 instead of COX pathway.
Partial antagonists are safer for use because they do not mobilize stem cells.
Market Summary
CXC chemokine receptor 4 (CXCR4) and...
Published: 4/8/2024
Contributor(s): Hyunsuk Shim, Renren Bai, Suazette Mooring
|